Search Results
Oct 24, 2025, 10:00 ET Family of Toddler files lawsuit alleging their son died due to daycare neglect
Junior's "other half" and "built-in best friend," according to the family, witnessed the tragedy and had to be pulled away from her twin brother's body". "Matthew Junior was, full of energy, full of smiles and full of love," said Renee Saavedra DeMotta, spokesperson for the family
More news about: The Law Firm of Gwilliam Ivary Chiosso Cavalli & Brewer
Oct 24, 2025, 09:01 ET Massage Envy Announces Scholarship Sweepstakes Winners
2008. The brand has over 1,000 franchise locations in 49 states that have together delivered more than 225 million services across its skin care and body care offerings. For more information, visit
More news about: Massage Envy
Oct 24, 2025, 09:00 ET With More Adults Admitting To Celebrating Halloween in 2025, THC Pioneer Delta Beverages Launches New Campaign To Own Spooky Season
Delta in hand. Not much scares him, aside from high-carb and artificially flavored pumpkin-spiced drinks. This Halloween, Drankula is having what your body is having, and he wants you to enjoy Delta THC seltzers that are zero sugar, zero calories, and all-natural so that you can participate in the festivities
More news about: Delta Beverages
Oct 24, 2025, 09:00 ET BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology
provide structural tissue for wound protection. BioLab's mission is to manufacture reliable and safe products with the highest quality to help optimize body performance through continuous innovation, education, superior customer service, and teamwork. About terraplasma
More news about: BioLab Holdings, Inc.
Oct 24, 2025, 08:00 ET Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases
new class of fully engineered circular RNA (oRNA®) therapeutics to unlock the potential of RNA medicine to treat diseases anywhere in the body. Orna's oRNA transcripts have advantages over traditional mRNA approaches, including simplified production, improved formulation into lipid nanoparticles,
More news about: Orna Therapeutics
Oct 24, 2025, 08:00 ET Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis
Dermatology Conference, simultaneously evaluated adults and adolescents with at least moderate scalp, genital and/or hand/foot plaque psoriasis with ≥1% Body Surface Area (BSA) affected. Through Week 52, icotrokinra demonstrated high and durable rates of site-specific psoriasis clearance affecting all of
More news about: Johnson & Johnson
Oct 24, 2025, 07:29 ET Sobi showcases new data across rare inflammatory conditions at ACR 2025
inflammatory arthritis with more than 8.3 million people in the United States having been diagnosed. Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain. Approximately 200,000 people in the United States
More news about: Swedish Orphan Biovitrum AB
Oct 24, 2025, 06:45 ET Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
chillsmuscle achescoughshortness of breathblood in phlegmweight loss warm, red, or painful skin or sores on your bodydiarrhea or stomach painburning with urination or urinating more often than normalfeeling tired
More news about: Eli Lilly and Company
Oct 24, 2025, 00:00 ET BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology
provide structural tissue for wound protection. BioLab's mission is to manufacture reliable and safe products with the highest quality to help optimize body performance through continuous innovation, education, superior customer service, and teamwork. About terraplasma
More news about: BioLab Holdings, Inc.
Oct 23, 2025, 20:00 ET Jacobio Presents Pre-Clinical Data of Pan-KRAS Inhibitor (JAB-23E73) at AACR-NCI-EORTC International Conference
mutations or amplification. In KRAS-driven mouse tumor models, JAB-23E73 induced tumor regression without causing significant body weight loss, indicating good tolerability and a wide therapeutic window. The compound also showed a favorable pharmacokinetic profile for oral administration
More news about: Jacobio Pharma
Oct 23, 2025, 18:01 ET /C O R R E C T I O N -- IFPA/
Psoriasis is not "just a skin disease" as it has been misunderstood for a long time. It is a lifelong, immune-mediated condition that affects the entire body. The body's immune system triggers an overproduction of skin cells, leading to painful, inflamed, and itchy plaques. But the damage goes far deeper than
More news about: IFPA
Oct 23, 2025, 16:51 ET World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis
Psoriasis is not "just a skin disease" as it has been misunderstood for a long time. It is a lifelong, immune-mediated condition that affects the entire body. The body's immune system triggers an overproduction of skin cells, leading to painful, inflamed, and itchy plaques. But the damage goes far deeper than
More news about: IFPA
Oct 23, 2025, 16:20 ET Elevate Holistics Empowers U.S. Veterans Through Medical Cannabis Access -- CEO Aspen Noonan Highlights New Federal & State-Level Progress
Noonan, Elevate Holistics is amplifying its veteran-centric initiatives: "Veterans deserve choices," says Noonan. "With the growing body of research and landmark policy reforms in 2025, we're focused on ensuring veterans can access medically-directed cannabis under physician guidance
More news about: Elevate Holistics
Oct 23, 2025, 16:05 ET INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit
More news about: INOVIO Pharmaceuticals, Inc.
Oct 23, 2025, 13:44 ET Meet Linear Bar: The Protein Bar That Tastes Like Candy and Fuels Like Superfood
better, as consumer taste expectations and demand for high-protein, on-the-go snacks continue to rise. Linear Bar has become a fast favorite in the body building community and is poised to become the new go-to for the many people focused on meeting their protein needs. In fact, a 2025
More news about: Linear Bar
Oct 23, 2025, 12:00 ET World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis
Psoriasis is not "just a skin disease" as it has been misunderstood for a long time. It is a lifelong, immune-mediated condition that affects the entire body. The body's immune system triggers an overproduction of skin cells, leading to painful, inflamed, and itchy plaques. But the damage goes far deeper than
More news about: IFPA
Oct 23, 2025, 11:52 ET Osmolality as a Key to Diagnosing Diabetes Insipidus, Upcoming Webinar Hosted by Xtalks
learn how osmolality testing supports the diagnosis and management of diabetes insipidus (DI). Attendees will gain insight into how serum osmolality and body weight measurements are used to proceed with a water deprivation test safely. The featured speaker will discuss how urine osmolality is used to assess
More news about: Xtalks
Oct 23, 2025, 10:26 ET Fisher College Selects NWN for Multi-Million Dollar Partnership to Power AI-Driven Campus Transformation and Esports Innovation
overall investment will be worth more than $2.5 million. Located in the heart of Boston, Fisher College serves a diverse student body of over 1,500 learners, including a high percentage of first-generation, part-time, and international students. With 62% female enrollment
More news about: NWN
Oct 23, 2025, 10:21 ET Continuum Marks One-Year Milestone and Expands Membership
sleep, performance, and recovery — generating real-time, adaptive direction. It functions as a personalized, living blueprint that evolves with the body, guiding training, recovery, and daily behaviors with clinical-level precision. Developed and validated in Continuum's high-touch
More news about: Continuum
Oct 23, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
issued a negative opinion on the request to approve the dosing regimen of 2 mg/kg body weight infused every 4 weeks (E4W) for Elfabrio (pegunigalsidase alfa, in addition to the currently approved dosing regimen of 1 mg/kg body weight infused every 2 weeks (E2W)." On this news, Protalix's
More news about: Pomerantz LLP
Oct 23, 2025, 10:00 ET InventHelp Inventor Develops Real-Time Monitoring System for Cortisol Levels (MBQ-743)
The patent-pending invention provides a way to continuously monitor cortisol levels in the body. In doing so, it enables users to monitor stress levels. As a result, it helps users better manage their health and wellness. The invention features
More news about: InventHelp
Oct 23, 2025, 10:00 ET Kyndryl named a Top 100 Most Loved Workplace® by the Wall Street Journal
organization that partners with corporations worldwide to optimize culture, performance, and talent strategy. BPI is the exclusive certifier and research body behind Most Loved Workplace®. About Kyndryl Kyndryl (NYSE: KD) is a leading
More news about: Kyndryl
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
pathway is a survival signal for mast cells and [the Company] believe[s] that blocking this pathway may lead to depletion of these cells throughout the body, including in the lungs and in the skin, which could lead to significant clinical benefit for patients with mast-cell driven diseases such as asthma
More news about: Pomerantz LLP
Oct 23, 2025, 09:05 ET Serta® Announces Debut Float in the 99th Macy's Thanksgiving Day Parade®
Serta® Zoned Comfort – targeted support across key areas of the body Individually-Wrapped Coil System – durable support and minimized motion transfer
More news about: Serta Simmons Bedding
Oct 23, 2025, 09:03 ET Finance Trailblazer Donna Gambrell Receives 2025 Ned Gramlich Lifetime Achievement Award for Responsible Finance
commitment to expanding economic opportunity. The spirit of the award is to celebrate people of distinction who have produced a body of work that sets them apart within the CDFI industry. These individuals have shaped the field through innovation, institution-building, and a relentless
More news about: Opportunity Finance Network